The Simulus ® Adjustable Annuloplasty Ring and Band are fully flexible and enable finite adjustments. Based on preference and patient need, surgeons can choose between the Simulus Adjustable ...

Medtronic is nearing a U.S. launch for its Hugo surgical robot more than three years after receiving approval to release the soft tissue system in Europe. CEO Geoff Martha told investors Tuesday that ...

Medtronic is nearing a U.S. launch for its Hugo surgical robot more than three years after receiving approval to release the soft tissue system in Europe. CEO Geoff Martha told investors Tuesday ...

How mission plus performance can lead to sustainable success. [Photos: Shari Fleming Photography/Medtronic; Lance Murphey/Bloomberg via Getty Images] When Geoff ...

When Geoff Martha, chairman and CEO of Medtronic, took over the medical device maker’s Restorative Therapies Group in 2015, the company faced a tough decision. The group at the time was ...

Medtronic has recalled systems for draining fluid from the brain because of the risk of cracks and leaks, the Food and Drug Administration said Monday. The agency published the Class I notice about ...

Medtronic (MDT) beat estimates for profits in the last quarter thanks to strong demand for diabetes and heart devices. Earnings per share of $1.39 increased 7% on last year in the Fiscal 2025 ...

Medical device manufacturer Medtronic (NYSE: MDT) is a healthcare industry stalwart. The company, based in the U.S. and Ireland, is one of the largest in its segment, developing and selling a ...

Medtronic brought in revenues of $8.3bn for the quarter, up 2.5% from the same period in 2024. Image credit: Shutterstock / JHVEPhoto. Medtronic posted a strong profit for Q3 of fiscal year 2025, ...

Medtronic missed Wall Street's fiscal 2025 Q3 revenue estimate but beat earnings expectations. The company's revenue miss appears to be primarily related to a temporary change in distributor ...

Medtronic shares tumbled after the medical device maker’s sales came in short of analysts' forecasts. Major U.S. indexes wavered between gains and losses at midday Tuesday ahead of fresh ...

Medtronic Q3 revenue of $8.29 billion missed estimates, but EPS of $1.39 beat the $1.36 consensus. Medtronic reaffirms FY25 organic growth guidance of 4.75%-5%. Our ...